Supplementary Figures S1-S8 from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figures S1-S8
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4385658331
